Cargando…

A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure

Patient: Male, 78 Final Diagnosis: Acute myeloid leukemia (AML) Symptoms: Dyspnea • fatigue Medication: Idarubicin followed by cytarabine Clinical Procedure: Chemotherapy Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Renal failure is a common presentation of acute myelomonocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapper, Elliot B., Luptakova, Katarina, Joyce, Robin M., Tzachanis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159241/
https://www.ncbi.nlm.nih.gov/pubmed/25184701
http://dx.doi.org/10.12659/AJCR.890798
_version_ 1782334179541778432
author Tapper, Elliot B.
Luptakova, Katarina
Joyce, Robin M.
Tzachanis, Dimitrios
author_facet Tapper, Elliot B.
Luptakova, Katarina
Joyce, Robin M.
Tzachanis, Dimitrios
author_sort Tapper, Elliot B.
collection PubMed
description Patient: Male, 78 Final Diagnosis: Acute myeloid leukemia (AML) Symptoms: Dyspnea • fatigue Medication: Idarubicin followed by cytarabine Clinical Procedure: Chemotherapy Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Renal failure is a common presentation of acute myelomonocytic and monocytic leukemia. It is usually the result of a combined glomerular and tubular dysfunction and is associated with a poor prognosis. No guidelines exist for treatment. CASE REPORT: We herein describe the case of a 78-year-old Caucasian man who presented with acute myeloid leukemia M5, leukostasis with a white count of 340 000/ml, and acute renal failure with a creatinine of 7.7/dL. The patient was initially treated with leukapheresis and 3 days of idarubicin in the setting of continuous renal replacement therapy that resulted in rapid reversal of his renal failure. He then received 7 days of continuous infusion cytarabine and went into a complete remission. CONCLUSIONS: Renal failure may complicate the presentation of AML but can be reversible with treatment. Dose adjustment of the chemotherapy is not needed and the treatment can be greatly facilitated with the use of continuous renal replacement therapy, as indicated in our case report. In addition, we emphasize that organ dysfunction, even in elderly patients, is not necessarily a contraindication to aggressive treatment if it is felt to be disease-related and reversible.
format Online
Article
Text
id pubmed-4159241
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-41592412014-09-10 A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure Tapper, Elliot B. Luptakova, Katarina Joyce, Robin M. Tzachanis, Dimitrios Am J Case Rep Articles Patient: Male, 78 Final Diagnosis: Acute myeloid leukemia (AML) Symptoms: Dyspnea • fatigue Medication: Idarubicin followed by cytarabine Clinical Procedure: Chemotherapy Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Renal failure is a common presentation of acute myelomonocytic and monocytic leukemia. It is usually the result of a combined glomerular and tubular dysfunction and is associated with a poor prognosis. No guidelines exist for treatment. CASE REPORT: We herein describe the case of a 78-year-old Caucasian man who presented with acute myeloid leukemia M5, leukostasis with a white count of 340 000/ml, and acute renal failure with a creatinine of 7.7/dL. The patient was initially treated with leukapheresis and 3 days of idarubicin in the setting of continuous renal replacement therapy that resulted in rapid reversal of his renal failure. He then received 7 days of continuous infusion cytarabine and went into a complete remission. CONCLUSIONS: Renal failure may complicate the presentation of AML but can be reversible with treatment. Dose adjustment of the chemotherapy is not needed and the treatment can be greatly facilitated with the use of continuous renal replacement therapy, as indicated in our case report. In addition, we emphasize that organ dysfunction, even in elderly patients, is not necessarily a contraindication to aggressive treatment if it is felt to be disease-related and reversible. International Scientific Literature, Inc. 2014-08-30 /pmc/articles/PMC4159241/ /pubmed/25184701 http://dx.doi.org/10.12659/AJCR.890798 Text en © Am J Case Rep, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Articles
Tapper, Elliot B.
Luptakova, Katarina
Joyce, Robin M.
Tzachanis, Dimitrios
A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title_full A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title_fullStr A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title_full_unstemmed A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title_short A 78-Year-Old Man with Acute Myeloid Leukemia (AML) and Acute Renal Failure
title_sort 78-year-old man with acute myeloid leukemia (aml) and acute renal failure
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159241/
https://www.ncbi.nlm.nih.gov/pubmed/25184701
http://dx.doi.org/10.12659/AJCR.890798
work_keys_str_mv AT tapperelliotb a78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT luptakovakatarina a78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT joycerobinm a78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT tzachanisdimitrios a78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT tapperelliotb 78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT luptakovakatarina 78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT joycerobinm 78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure
AT tzachanisdimitrios 78yearoldmanwithacutemyeloidleukemiaamlandacuterenalfailure